Phlebotonics vs placebo?: Adverse events
Do phlebotonics improve signs and symptoms of venous insufficiency… probably leads to higher adverse events compared with placebo? (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Do phlebotonics improve signs and symptoms of venous insufficiency when vs placebo? Adverse events · patients with venous insufficiency Do phlebotonics improve signs and symptoms of venous insufficiency… probably leads to higher adverse events compared with placebo? (moderate certainty). Phlebotonics for venous insufficiency (2020) · Cochrane Headline outcomes only | RR 1.14 [1.02, 1.27] | 37 studies · 5789 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Phlebotonics for venous insufficiency 2020 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.